Cholesterol-modified Hydroxychloroquine-loaded Nanocarriers in Bleomycin-induced Pulmonary Fibrosis

An increasing number of reports have suggested the use of hydroxychloroquine (HCQ) as an adjunct anti-cancer treatment to enhance the chemotherapeutic response, as well as for the treatment of several fibrotic skin diseases and cystic fibrosis. In this study, we synthesized a cholesterol-modified HC...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Sci Rep
Asıl Yazarlar: Liu, Li, Ren, Jun, He, Zhiyao, Men, Ke, Mao, Ye, Ye, Tinghong, Chen, Hua, Li, Ling, Xu, Bocheng, Wei, Yuquan, Wei, Xiawei
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group UK 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5587549/
https://ncbi.nlm.nih.gov/pubmed/28878315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-11450-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller